A simulation model approach to analysis of the business case for eliminating health care disparities

BMC Medical Research Methodology

Volumn 11, Issue , 2011, Pages

  Nerenz, David R ^a   Liu, Yung Wen ^b   Williams, Keoki L ^a   Tunceli, Kaan ^a   Zeng, Huiwen ^c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b University of Michigan Dearborn   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASTHMA; BREAST TUMOR; CHILD; COMPUTER SIMULATION; ECONOMICS; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; HUMAN; LIFE EXPECTANCY; MAMMOGRAPHY; MIDDLE AGED; QUALITY ADJUSTED LIFE YEAR; THEORETICAL MODEL;

ABSENTEEISM; ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; ASTHMA; BREAST NEOPLASMS; CHILD; COMPUTER SIMULATION; EMPLOYER HEALTH COSTS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HEALTHCARE DISPARITIES; HUMANS; LIFE EXPECTANCY; MAMMOGRAPHY; MIDDLE AGED; MODELS, THEORETICAL; PREPAID HEALTH PLANS; QUALITY OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; YOUNG ADULT;

EID: 79953082655     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-11-31     Document Type: Article

References (106)

1. KS Collins A Hall C Neuhaus, U.S. Minority Health: A Chartbook New York: The Commonwealth Fund 1999
2. Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. K Fiscella P Franks MR Gold CM Clancy, JAMA 2000 283 2579 2584 10.1001/jama.283.19.2579 10815125 (Pubitemid 30324204)
3. Health care organizations' use of data on race/ethnicity to address disparities in health care. DR Nerenz KA Hunt JJ Escarce, Health Serv Res 2006 41 1444 1450 10.1111/j.1475-6773.2006.00613.x 16899017 (Pubitemid 44114607)
4. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. BD Smedley AY Stith AR Nelson (Eds), Washington, DC: National Academy Press 2002
5. Class - the ignored determinant of the nation's health. SL Isaacs SA Schroeder, New Engl J Med 2004 351 1137 1142 10.1056/NEJMsb040329 15356313 (Pubitemid 39167519)
6. Disparities in health care by race, ethnicity, and language among the insured. K Fiscella P Franks MP Doescher BG Saver, Race, Ethnicity, and Health San Francisco: Jossey-Bass, LaVeist TA, 2002
7. Sociodemographic differences in the receipt of colorectal cancer surveillance care following treatment with curative intent. J Elston Lafata C Cole Johnson T Ben-Menachem RJ Morlock, Med Care 2001 39 361 372 10.1097/00005650-200104000-00007 11329523 (Pubitemid 33603635)
8. Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: Opportunity for improvement. K Wisdom JP Fryzek SL Havstad RM Anderson MC Dreiling BC Tilley, Diabetes Care 1997 20 971 977 10.2337/diacare.20.6.971 9167108 (Pubitemid 27224947)
9. Eliminating racial/ethnic disparities in health care: Can health plans generate reports? DR Nerenz V Bonham R Green-Weir C Joseph M Gunter, Health Affairs 2002 21 May/June 259 263 10.1377/hlthaff.21.3.259 12025992
10. DR Nerenz MJ Gunter M Garcia RR Green-Weir K Wisdom C Joseph, Developing a Health Plan Report Card on Quality of Care for Minority Populations New York: The Commonwealth Fund 2002
11. Health care organizations' use of information on race/ethnicity to address disparities in quality of care. DR Nerenz, Health Affairs 2005 24 2 409 416 10.1377/hlthaff.24.2.409 15757924 (Pubitemid 40528960)
12. Verizon works to eliminate disparities in health care for its diverse workforce. AC Izlar, Health Affairs 2005 24 2 421 423 10.1377/hlthaff.24.2.421 15757926 (Pubitemid 40528962)
13. Engagement of health plans and employers in addressing racial and ethnic disparities in health care. MB Rosenthal BE Landon SL Normand TS Ahmad AM Epstein, Med Care Res Review 2009 66 2 219 231 10.1177/1077558708328816
14. How to present the business case for healthcare quality to employers. S Nicholson MV Pauly D Polsky CM Baase GM Billotti RJ Ozminkowski ML Berger CE Sharda, Appl Health Econ Health Pol 2005 4 209 218 10.2165/00148365-200504040- 00003 (Pubitemid 43242209)
15. National Committee for Quality Assurance, The State of Health Care Quality 2004 Washington, DC: NCQA 2004
16. Evaluation health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: A nationwide, population-based assessment. CY Ko M Maggard EH Livingston, J Surg Res 2003 114 1 5 10.1016/S0022-4804(03)00167-7 13678691 (Pubitemid 37108668)
17. Breast cancer - race, ethnicity, and survival: a literature review. JB Campbell, Breast Cancer Res Treat 2002 74 187 192 10.1023/A:1016178415129 12186379 (Pubitemid 34816224)
18. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. LL Humphrey M Helfand BKS Chan SH Woolf, Ann Intern Med 2002 137 347 360 12204020 (Pubitemid 34977137)
19. Screening for breast cancer. DM Eddy, Ann Intern Med 1989 111 389 399 2504094 (Pubitemid 19231293)
20. HEDIS Archives. NCQA, http://www.ncqa.org/tabid/346/Default.aspx
21. KS Collins A Hall C Neuhaus, U.S. Minority Health: A Chartbook New York: The Commonwealth Fund 1999
22. Breast cancer screening practices among Black, Hispanic, and White women: Reassessing differences. DN Pearlman W Rakwoski B Ehrich MA Clark, Am J Preventive Med 1996 12 327 337 (Pubitemid 26376172)
23. Racial disparities in the quality of care for enrollees in Medicare managed care. EC Schneider AM Zaslavsky AM Epstein, JAMA 2002 287 1288 1294 10.1001/jama.287.10.1288 11886320 (Pubitemid 34250483)
24. Breast cancer screening use by African Americans and Whites in an HMO. LM Reisch MB Barton SW Fletcher W Kreuter JG Elmore, J Gen Intern Med 2000 15 229 234 10.1111/j.1525-1497.2000.01339.x 10759997 (Pubitemid 30241268)
25. Benefits and costs of interventions to improve breast cancer outcomes in African American women. JS Mandelblatt CB Schechter KR Yabroff W Lawrence J Dignam P Muennig Y Chavez J Cullen M Fahs, J Clin Oncol 2004 22 2554 2566 10.1200/JCO.2004.05.009 15173213 (Pubitemid 41109930)
26. Surveilance for asthma - United States, 1980-1999. DM Mannino DM Homa LJ Akinbami JE Moorman C Gwynn SC Redd, MMWR Surveillance Summaries 2002 51 1 13
27. Asthma prevalence and control characteristics by race/ethnicity - United States, 2002. MMWR Weekly 2004 53 145 148
28. Reducing disparities in asthma care: Priorities for research - National Heart, Lung, and Blood Institute Workshop Report. RC Strunk JG Ford V Taggart, J Allergy Clin Immunol 2002 109 229 237 10.1067/mai.2002.120950 11842290 (Pubitemid 34158286)
29. Low-dose inhaled corticosteroids and the prevention of death from asthma. S Suissa P Ernst S Benayoun M Baltzan B Cai, New Engl J Med 2000 343 332 336 10.1056/NEJM200008033430504 10922423 (Pubitemid 30616699)
30. A childhood asthma severity scale: Symptoms, medications, and health care visits. AN Ortega KD Belanger MB Bracken BP Leaderer, Ann Allergy Asthma Immunol 2001 86 405 413 10.1016/S1081-1206(10)62486-6 11345283 (Pubitemid 32332319)
31. Self-reported asthma and health-related quality of life. ES Ford DM Mannino DM Homa C Gwynn SC Redd DG Moriarty AH Mokdad, Chest 2003 123 119 127 10.1378/chest.123.1.119 12527612
32. A cross-sectional analysis of work-related outcomes in adults with asthma. SR Erickson DM Kirking, Ann Allergy Asthma Immunol 2002 88 292 300 10.1016/S1081-1206(10)62011-X 11926623 (Pubitemid 34245974)
33. National Asthma Education and Prevention Program: Expert Panel Report. Heart National, Lung, and Blood Institute, J Allergy Clin Immunol 1991 88 425 534 10.1016/0091-6749(91)92135-N 1890276
34. Does the HEDIS asthma measure go far enough? JH Glauber, Am J Managed Care 2001 7 575 579 (Pubitemid 32564847)
35. National Committee on Quality Assurance, State of Health Care Quality Report, 2008 Washington, DC: NCQA 2008
36. Impact of site of care, race, and Hispanic ethnicity on medication use for childhood asthma. AN Ortega PJ Gergen AD Paltiel H Bauchner KD Belanger BP Leaderer, Pediatrics 2002 109 1 6 10.1542/peds.109.1.e1 11773569
37. Race and sex differences in consistency of care with national asthma guidelines in managed care organizations. JA Krishnan GB Diette EA Skinner BD Clark D Steinwachs AW Wu, Arch Intern Med 2001 161 1660 1668 10.1001/archinte.161.13.1660 11434799 (Pubitemid 32681149)
38. Asthma symptoms, morbidity, and anti-inflammatory use in inner-city children. KL Warman EJ Silver REK Stein, Pediatrics 2001 108 277 282 10.1542/peds.108.2.277 11483788
39. Medications used by children with asthma living in the inner city. PA Eggleston FJ Malveaux AM Butz K Huss L Thompson K Kolodner CS Rand, Pediatrics 1998 101 349 354 10.1542/peds.101.3.349 9480996 (Pubitemid 28136405)
40. How does home management of asthma exacerbations by parents of inner-city children differ from NHLBI guideline recommendations? KL Warman EJ Silver MP McCourt REK Stein, Pediatrics 1999 103 422 427 10.1542/peds.103.2.422 9925835 (Pubitemid 29274536)
41. A comprehensive study of the direct and indirect costs of adult asthma. MG Cisternas PD Blanc IH Yen PP Katz G Earnest MD Eisner S Shiboski EH Yelin, J Allergy Clin Immunol 2003 111 1212 1218 10.1067/mai.2003.1449 12789219 (Pubitemid 36683672)
42. Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population. G Colice EQ Wu H Birnbaum M Daher MB Marynchenko S Varghese, J Occup Environ Med 2006 48 794 802 10.1097/01.jom. 0000229819.26852.0e 16902372 (Pubitemid 44221834)
43. The economic burden of asthma: Direct and indirect costs in Switzerland. TD Szucs H Anderhub M Rutishauser, Eur Resp J 1999 13 281 286 10.1034/j.1399-3003.1999.13b10.x (Pubitemid 29086820)
44. NCQA, HEDIS 2009 Washington, DC: National Committee for Quality Assurance 2009 2
45. An introduction to Markov modeling for economic evaluation. A Briggs M Sculpher, Pharmacoeconomics 1998 13 397 409 10.2165/00019053-199813040-00003 10178664 (Pubitemid 28140699)
46. Wages by Area and Occupation. Bureau of Labor Statistics, http://www.bls.gov/bls/blswage.htm
47. J Harris J Brannick, Finding and Keeping Great Employees New York: AMA Publications 1999
48. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. SH Taplin W Barlow N Urban MT Mandelson DJ Timlin L Ichikawa P Nefcy, J Natl Cancer Inst 1995 87 417 426 10.1093/jnci/87.6.417 7861461
49. Mammographic screening for breast cancer. SW Fletcher JG Elmore, N Eng J Med 2003 348 1672 1680 10.1056/NEJMcp021804 (Pubitemid 36459474)
50. Systematic review: The long-term effects of false-positive mammograms. NT Brewer T Salz SE Lille, Ann Int Med 2007 146 502 510 17404352 (Pubitemid 351650559)
51. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: Results from the Asthma Policy Model. AD Paltiel AL Fuhlbrigge BT Kitch B Liljas ST Weiss PJ Neumann KM Kuntz, J Allergy Clin Immunol 2001 108 39 46 10.1067/mai.2001.116289 11447380 (Pubitemid 32662230)
52. Consumer Reports, Consumer Reports Best Buy Drugs 2006 http://www.CRBestBuyDrugs.org
53. The Canadian National Breast Screening Study - 1: Breast cancer mortality after 11 to 16 years of follow-up: A randomized screening trial of mammography in women age 40 to 49 years. AB Miller T To CJ Baines C Wall, Ann Intern Med 2002 137 305 E315
54. The cost-effectiveness of improving diabetes care in U.S. Federally Qualified Community Health Centers. ES Huang Q Zhang SE Brown ML Drum DO Meltzer MH Chin, Health Serv Res 2007 42 2174 2193 10.1111/j.1475-6773.2007.00734.x 17995559 (Pubitemid 350077336)
55. The value of ambulatory care measures: A review of clinical and financial impact from an employer/payer perspective. F deBrantes PS Wickland JP Williams, Am J Manag Care 2008 14 360 368 18554074 (Pubitemid 351934126)
56. Selecting high priority quality measures for breast cancer quality improvement. MJ Hassett ME Hughes JC Niland R Ottesen SB Edge MA Bookman RW Carlson RL Theriault JC Weeks, Med Care 2008 46 762 770 10.1097/MLR. 0b013e318178ead3 18665055
57. What is the most cost-effective population-based cancer screening program for Chinese women? PPS Woo JJ Kim GM Leung, J Clin Oncol 2007 25 617 624 10.1200/JCO.2006.06.0210 17308266 (Pubitemid 350002915)
58. Challenges to using a business case for addressing health disparities. N Lurie SA Somers A Fremont J Angeles EK Murphy A Hamblin, Health Affairs 2008 27 334 338 10.1377/hlthaff.27.2.334 18332487 (Pubitemid 351490326)
59. Black women receive less mammography even with similar use of primary care. RB Burns EP McCarthy KM Freund SL Marwill M Shwartz A Ash MA Moskowitz, Ann Intern Med 1996 125 173 182 8686974 (Pubitemid 126449259)
60. Race and mammography use in two North Carolina counties. MS O'Malley JL Earp RP Harris, Am J Pub Health 1997 87 782 786 (Pubitemid 27247201)
61. Comparison of mammography use by older Black and White women. B Han BL Wells M Primas, J Am Geriatric Soc 2003 51 203 212 10.1046/j.1532-5415.2003. 51059.x (Pubitemid 36205849)
62. Breast and cervical cancer screening: Sociodemographic predictors among White, Black, and Hispanic women. E Selvin KM Brett, Am J Pub Health 2003 93 618 623 10.2105/AJPH.93.4.618 (Pubitemid 36790882)
63. Mammographic screening: Patterns of use and estimated impact on breat carcinoma survival. K Blanchard JA Colbert D Puri J Weissman B Moy DB Kopans EM Kaine RH Moore EF Halpern KS Hughes KK Tanabe BL Smith JS Michaelson, Cancer 2004 101 495 507 10.1002/cncr.20392 15274062 (Pubitemid 38970600)
64. EJ Feuer LM Wun, DEVCAN: Probability of developing or dying of cancer software, Version 5.0 National Cancer Institute 1999 http://surveillance.cancer. gov/devcan/
65. Surveillance, Epidemiology, and End Results (SEER) Program ( http://www.seer.cancer.gov ) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov. 2002 Sub (1973-2000), NCI, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Released April 2003, based on the November 2002 submission
66. National Cancer Institute, SEER Cancer Statistics Review 1975-2000. (Table IV-3) Bethesda, MD: National Cancer Institute
67. Will screening mammography in the East do more harm than good? GM Leung TH Lam TQ Thach AJ Hedley, Am J Pub Health 2002 92 1841 1846 10.2105/AJPH.92.11.1841 (Pubitemid 35231149)
68. Mammography and breast cancer detection by race and Hispanic ethnicity: Results from a national program (United States). DS May NC Lee LC Richardson AG Giustozzi JK Bobo, Cancer Cause Control 2000 11 697 705 10.1023/A:1008900220924
69. Positive predictive value of screening mammography by age and family history of breast cancer. K Kerlikowske D Grady J Barclay EA Sickles A Eaton V Ernster, JAMA 1993 270 2444 2450 10.1001/jama.270.20.2444 8230621 (Pubitemid 23342293)
70. Mammography screening and differences in stage of disease by race/ethnicity. J Jacobellis G Cutter, Am J Pub Health 2002 92 1144 1150 10.2105/AJPH.92.7.1144 (Pubitemid 34700982)
71. Differences in breast cancer stage, treatment, and survival by race and ethnicity. CI Li KE Malone JR Daling, Arch Intern Med 2003 16 49 56 10.1001/archinte.163.1.49 (Pubitemid 36091600)
72. Race and differences in breast cancer survival in a managed care population. MU Yood CC Johnson A Blount J Abrams E Wolman BD McCarthy U Raju DS Nathanson M Worsham SR Wolman, J Natl Cancer Inst 1999 91 1487 1491 10.1093/jnci/91.17.1487 10469750 (Pubitemid 29424554)
73. Racial disparities in breast carcinoma survival rates: Separating factors that affect diagnosis from factors that affect treatment. KC Chu CA Lamar HP Freeman, Cancer 2003 97 2853 2860 10.1002/cncr.11411 12767100 (Pubitemid 36605155)
74. The relationship between access and stage at diagnosis of breast cancer in African American and Caucasian women. SC Bibb, Oncol Nurs Forum 2001 28 711 719 11383185
75. Biennial versus annual mammography and the risk of late-stage breast cancer. E White DL Miglioretti BC Yankaskas BM Geller RD Rosenberg K Kerlikowske L Saba PM Vacek PA Carney DS Buist N Oestreicher W Barlow R Ballard-Barbash SH Taplin, J Natl Cancer Inst 2004 96 1832 1839 10.1093/jnci/djh337 15601639 (Pubitemid 40081320)
76. Race, anthropometric factors, and stage at diagnosis of breast cancer. PG Moorman BA Jones RC Millikan IJ Hall B Newman, Am J Epidemiol 1999 153 284 291 10.1093/aje/153.3.284
77. Racial differences in breast carcinoma survival. SA Joslyn MM West, Cancer 2000 88 114 123 10.1002/(SICI)1097-0142(20000101)88:1<114::AID- CNCR163.0.CO;2-J 10618613 (Pubitemid 30027686)
78. Early adult characteristics and mortality among inner-city African American women. NM Astone M Ensminger HS Juon, Am J Pub Health 2002 92 640 645 10.2105/AJPH.92.4.640 (Pubitemid 34246027)
79. Estimating treatment benefits for the elderly: The effect of competing risks. HG Welch PC Albertsen RF Nease TA Bubolz JH Wasson, Ann Intern Med 1996 124 577 584 8597322 (Pubitemid 26085060)
80. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer: A decision-analytic model. BE Hillner TJ Smith, N Engl J Med 1991 324 160 168 10.1056/NEJM199101173240305 1898533
81. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive and BRCA2-positive patients. VR Grann KS Panageas W Whang KH Antman AI Neugut, J Clin Oncol 1998 16 979 985 9508180 (Pubitemid 28108730)
82. Systematic overview of cost-utility assessments in oncology. CC Earle RH Chapman CS Baker CM Bell PW Stone EA Sandberg PJ Neumann, J Clin Oncol 2000 18 3302 3317 10986064
83. Economic evaluation of breast cancer treatment: considering the value of patient choice. D Polsky JS Mandelblatt JC Weeks L Venditti YT Hwang HA Glick J Hadley KA Schulman, J Clin Oncol 2003 21 1139 1146 10.1200/JCO.2003.03.126 12637482 (Pubitemid 46594145)
84. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients. JH Lee HA Glick JA Hayman LJ Solin, J Clin Oncol 2002 20 2713 2725 10.1200/JCO.2002.07.008 12039934 (Pubitemid 34575645)
85. Continuing screening mammography in women aged 70 to 79 years: Impact on life expectancy and cost-effectiveness. K Kerlikowske P Salzmann KA Phillips JA Cauley SR Cummings, JAMA 1999 282 2156 2163 10.1001/jama.282.22.2156 10591338
86. Factors influencing quality of life in breast cancer survivors. PM Vacek P Winstead-Fry RH Secker-Walker GJ Hooper DA Plante, Quality Life Res 2002 12 527 537 10.1023/A:1025098108717
87. Data 4.0 Healthcare User's Manual Williamstown, MA: TreeAge Software, Inc 2002
88. Breast cancer and women's labor supply. CJ Bradley HL Bednarek D Neumark, Health Serv Res 2002 37 1309 1328 10.1111/1475-6773.01041 12479498 (Pubitemid 35398461)
89. Breast cancer, survival, work, and earnings. CJ Bradley HL Bednarek D Neumark, J Health Econ 2002 21 757 779 10.1016/S0167-6296(02)00059-0 12349881
90. Employment pathways in a large cohort of adult cancer survivors. PF Short JJ Vasey K Tunceli, Cancer 2005 103 1292 1301 10.1002/cncr.20912 15700265 (Pubitemid 40328102)
91. Short-term effects of breast cancer on labor market attachment: Results from a longitudinal study. CJ Bradley D Neumark HL Bednarek M Schenk, J Health Econ 2005 24 137 160 10.1016/j.jhealeco.2004.07.003 15617792 (Pubitemid 40023076)
92. Returning to work after breast cancer. R Eversley, http://www.cbcrp.org/ research/PageGrant.asp?grant-id=2108
93. The likelihood of returning to work after breast cancer. WA Satariano GN DeLorenze, Public Health Reports 1996 111 236 241 8643814 (Pubitemid 126510145)
94. Absenteeism from work: the experience of employed breast and prostate cancer patients in the months following diagnosis. CJ Bradley K Oberst M Schenk, Psychooncology 2006 15 739 47 10.1002/pon.1016 16374893 (Pubitemid 44251666)
95. Racial/ethnic variation in asthma status and management practices among children in managed Medicaid. TA Lieu P Lozano JA Finkelstein FW Chi NG Jensvold AM Capra CP Quesenberry JV Selby HJ Farber, Pediatrics 2002 109 857 865 10.1542/peds.109.5.857 11986447 (Pubitemid 34493353)
96. The State of Health Care Quality. NCQA, 2009 http://www.ncqa.org/Portals/ 0/Newsroom/SOHC/SOHC-2009.pdf
97. Modifiable barriers to adherence to inhaled steroids among adults with asthma: It's not just black and white. AJ Apter RC Boston M George T Norfle Tenhave JC Coyne K Birck ST Reisine AJ Cucchiara HI Feldman,, et al. J Allergy Clin Immunol 2003 111 1219 1226 10.1067/mai.2003.1479 12789220 (Pubitemid 36683673)
98. Compliance with national asthma management guidelines and specialty care: A health maintenance organization experience. AP Legorreta J Christian-Herman RD O'Connor MM Hasan R Evans KM Leung, Arch Intern Med 1998 158 457 464 10.1001/archinte.158.5.457 9508223 (Pubitemid 128681606)
99. Modifiable risk factors for suboptimal control and controller medication underuse among children with asthma. LA Smith B Bokhour KH Hohman I Miroshnik KP Kleinman E Cohn DE Cortés A Galbraith C Rand TA Lieu, Pediatrics 2008 122 760 769 10.1542/peds.2007-2750 18829799
100. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. DD Sin SF Mann, Arch Intern Med 2002 162 1591 1595 10.1001/archinte.162.14.1591 12123402 (Pubitemid 34765008)
101. Pharmacological management to reduce exacerbations in adults with asthma: A systematic review and meta-analysis. DD Sin J Man H Sharpe WQ Gan SF Man, JAMA 2004 292 367 376 10.1001/jama.292.3.367 15265853 (Pubitemid 38944262)
102. Acute asthma among adults presenting to the emergency department. ED Beaudreaux SP Emond S Clark CA Camargo, Chest 2003 124 803 812 10.1378/chest.124.3.803 12970001
103. Health service use by African Americans and Caucasians with asthma in a managed care setting. EM Zoratti S Havstad J Rodriguez Y Robens-Paradise JE Lafata B McCarthy, Am J Respir Crit Care Med 1998 158 371 377 9700109 (Pubitemid 28378161)
104. Inhaled steroids and the risk of hospitalization for asthma. JG Donahue ST Weiss JM Livingston MA Goetsch DK Greineder R Platt, JAMA 1997 277 887 891 10.1001/jama.277.11.887 9062326 (Pubitemid 27123948)
105. What is the cost of asthma to employers? A Atherly SG Williams SC Redd, Drug Benefit Trends 2003 15 35 46
106. Retrospective cost-effectiveness analysis of screening mammography. NK Stout MA Rosenberg A Trentham-Dietz MA Smith SM Robinson DG Fryback, J Natl Cancer Inst 2006 98 774 782 10.1093/jnci/djj210 16757702 (Pubitemid 43983301)